메뉴 건너뛰기




Volumn 7, Issue 6, 2001, Pages 504-510

A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTIVIRUS AGENT; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

EID: 0034965224     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.24896     Document Type: Article
Times cited : (69)

References (31)
  • 1
    • 85031510736 scopus 로고    scopus 로고
    • Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network--Transplant Data: 1988-1998. Transplant Recipients Characteristics, Table 22. UNOS, Department of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD
    • (1998)
  • 8
    • 0033743167 scopus 로고    scopus 로고
    • An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
    • (2000) Liver Transpl , vol.6 , pp. 741-748
    • Han, S.H.1    Ofman, J.2    Holt, C.3    King, K.4    Kunder, G.5    Chen, P.6
  • 11
    • 0025825169 scopus 로고
    • Liver transplantation for patients with hepatitis B: What have we learned from our results?
    • (1991) Hepatology , vol.13 , pp. 796-798
    • Lake, J.R.1    Wright, T.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.